← Evidence map

RetractedArticleEvidence-based complementary and alternative medicine : eCAM2021

Osimertinib Improves Overall Survival in Patients with Leptomeningeal Metastases Associated with

Milan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34457028